Each colour maps a published value to the exact source passage used to support it. Only bounded excerpts are public; administrators can inspect the complete captured source.
Title
Onc.AI accelerates precision oncology with the Valohai MLOps platform and Oracle Cloud
Onc.AI accelerates precision oncology with the Valohai MLOps platform and Oracle Cloud Skip to content Accessibility Policy Menu QUICK LINKS Cloud Database Java AI SU…
Description
Onc.AI, a precision oncology company developing imaging biomarkers to predict patient survival and treatment responses from CT scans, deployed the Valohai MLOps platform on Oracle Cloud Infrastructure using OCI A10 GPU instances. The move doubled the company's biomarker pipeline speed and reduced deep learning training run costs by 50% compared with its previous GCP T4 GPUs, while supporting clinical-ready compliance.
…and bring AI-driven advances into oncology practice. ” Petr Jordan CTO, Onc.AI Onc.AI is a precision oncology company revolutionizing cancer care by developing advanced imaging biomarkers that help oncologists and pharmaceutical researchers predict patient survival and treatment responses. The company’s mission relies on analyzing thousands of longitudinal CT scans—a challenge requiring massive compute resources, rigorous compliance controls, and cost-effective operations. With its previous infrastructure, limited access to high performance GPUs restr…
…raining and validating complex deep learning models. To address these barriers, Onc.AI deployed the Valohai enterprise MLOps platform on Oracle Cloud Infrastructure (OCI) and transitioned its workflows to OCI’s A10 GPU instances. The move has doubled the company’s biomarker pipeline speed and reduced trainin…
…Infrastructure (OCI) and transitioned its workflows to OCI’s A10 GPU instances. The move has doubled the company’s biomarker pipeline speed and reduced training run costs by 50% compared with its previous GCP T4 GPUs, all while facilitating clinical-ready compliance, flexible distributed cloud deployment, and simplified operational overhead. OCI AI infrastructure enables Onc.AI to move from experimentation to clinical d…
Company
Onc.AI
…and bring AI-driven advances into oncology practice. ” Petr Jordan CTO, Onc.AI Onc.AI is a precision oncology company revolutionizing cancer care by developing advanced imaging biomarkers that help oncologists and pharmaceuti…
Country
United States
…biomarker development, cut deep learning costs by 50%, and enhance compliance. United States | Healthcare “ With Oracle Cloud’s A10 GPUs powering our Valohai workflows, we’ve doubled th…
Industry
Healthcare
…biomarker development, cut deep learning costs by 50%, and enhance compliance. United States | Healthcare “ With Oracle Cloud’s A10 GPUs powering our Valohai workflows, we’ve doubled th…
Problem
Onc.AI's mission of analyzing thousands of longitudinal CT scans to develop imaging biomarkers required massive compute resources, rigorous compliance controls, and cost-effective operations, but its previous infrastructure's limited access to high-performance GPUs restricted scalability and increased the cost of training and validating complex deep learning models.
…nd pharmaceutical researchers predict patient survival and treatment responses. The company’s mission relies on analyzing thousands of longitudinal CT scans—a challenge requiring massive compute resources, rigorous compliance controls, and cost-effective operations. With its previous infrastructure, limited access to high performance GPUs restricted scalability and increased the costs of training and validating complex deep learning models. To address these barriers, Onc.AI deployed the Valohai enterprise MLOps platfor…
Solution
Onc.AI deployed the Valohai enterprise MLOps platform on Oracle Cloud Infrastructure (OCI) and transitioned its workflows from GCP T4 GPUs to OCI's A10 GPU instances.
…raining and validating complex deep learning models. To address these barriers, Onc.AI deployed the Valohai enterprise MLOps platform on Oracle Cloud Infrastructure (OCI) and transitioned its workflows to OCI’s A10 GPU instances. The move has doubled the company’s biomarker pipeline speed and reduced trainin…
Business value
The move doubled Onc.AI's biomarker pipeline and training/validation speed and reduced training run costs by 50% compared with its previous GCP T4 GPUs, while facilitating clinical-ready compliance, flexible distributed cloud deployment, and simplified operational overhead.
…Infrastructure (OCI) and transitioned its workflows to OCI’s A10 GPU instances. The move has doubled the company’s biomarker pipeline speed and reduced training run costs by 50% compared with its previous GCP T4 GPUs, all while facilitating clinical-ready compliance, flexible distributed cloud deployment, and simplified operational overhead. OCI AI infrastructure enables Onc.AI to move from experimentation to clinical d…
AI capabilities
AI Model Development & MLOps, Computer Vision, Predictive Analytics
…raining and validating complex deep learning models. To address these barriers, Onc.AI deployed the Valohai enterprise MLOps platform on Oracle Cloud Infrastructure (OCI) and transitioned its workflows to OCI’s A10 GPU instances. The move has doubled…
…O, Onc.AI Onc.AI is a precision oncology company revolutionizing cancer care by developing advanced imaging biomarkers that help oncologists and pharmaceutical researchers predict patient survival and treatment responses. The company’s mission relies on analyzing thousands of longitudinal CT scans—a…
Technology
Valohai, Oracle Cloud Infrastructure (OCI), OCI A10 GPUs, OCI AI Infrastructure
…accelerates precision oncology with the Valohai MLOps platform and Oracle Cloud Onc.AI runs the Valohai platform on OCI’s powerful A10 GPUs to speed up biomarker development, cut deep learning costs by 50%, and enhance compliance. United States | Healthcare “ With Oracle Cloud’s A10 GPUs powering our Valohai…
…ce, flexible distributed cloud deployment, and simplified operational overhead. OCI AI infrastructure enables Onc.AI to move from experimentation to clinical deployment rapidly and securely, helping the company deliver solutions that empower clinicians and pharma partn…
Deployment model
Cloud (Oracle Cloud Infrastructure)
…raining and validating complex deep learning models. To address these barriers, Onc.AI deployed the Valohai enterprise MLOps platform on Oracle Cloud Infrastructure (OCI) and transitioned its workflows to OCI’s A10 GPU instances. The move has doubled…
Deployment options
cloud
…raining and validating complex deep learning models. To address these barriers, Onc.AI deployed the Valohai enterprise MLOps platform on Oracle Cloud Infrastructure (OCI) and transitioned its workflows to OCI’s A10 GPU instances. The move has doubled…
Headline outcome
…Infrastructure (OCI) and transitioned its workflows to OCI’s A10 GPU instances. The move has doubled the company’s biomarker pipeline speed and reduced training run costs by 50% compared with its previous GCP T4 GPUs, all while facilitating clinical-ready compliance, flexible distributed cloud deployment, and simplified operational overhead. OCI AI infrastructure enables Onc.AI to move from experimentation to clinical d…
Use case type
Decision support
…nc.AI to move from experimentation to clinical deployment rapidly and securely, helping the company deliver solutions that empower clinicians and pharma partners to make timely, data-informed decisions, accelerate drug development, and enhance patient outcomes. Learn more about Onc.AI Products list OCI AI Infrastructure 2026 Oracle Privac…
